Sobi vidareutvecklar Gamifant® (emapalumab) vid gammainterferon-driven sepsis (IDS) baserat på topline-data från EMBRACE (2) ...
In 2020, Ashley Harms, Ph.D., and University of Alabama at Birmingham colleagues published an Acta Neuropathologica study that used a mouse model to show that the alpha-synuclein pathology from ...
Validated Assay Can Test for Interferon Activity in Pediatric Inflammatory Diseases Using Biomarkers
CHICAGO — The use of a clinically validated flow cytometry test can assess type 1 and type 2 interferon activity in children with various pediatric inflammatory diseases to evaluate and monitor their ...
Sobi to advance Gamifant in interferon-gamma-driven sepsis based on EMBRACE topline data: Stockholm Friday, January 9, 2026, 11:00 Hrs [IST] Sobi, a global biopharma company, anno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback